Angiotensin-converting enzyme inhibitors: Mechanism of action and implications in anesthesia practice

被引:51
作者
Behnia, R
Molteni, A
Igic, R
机构
[1] John H Stroger Jr Hosp Cook Cty, Dept Anesthesiol & Pain Management, Chicago, IL 60612 USA
[2] Rush Med Coll, Chicago, IL 60612 USA
[3] Univ Missouri, Dept Pathol & Pharmacol, Kansas City, MO 64110 USA
关键词
renin-angiotensin-aldosterone system; angiotensin receptors; angiotensin I converting enzyme inhibitors; systemic and pulmonary hypertension; organ injury and protection; anesthetic agents; anesthesia;
D O I
10.2174/1381612033455413
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review summarizes physiology of circulating and local renin-angiotensin system (RAS), enzymatic properties and mechanism of action of angiotensin I converting enzyme inhibitors (ACEIs) on RAS, and implications of ACEIs in anesthetic management of patients treated with these drugs. ACEIs, through their effect on RAS, may improve cardiovascular functions, pulmonary dynamics, and body fluid homeostasis. Thus, ACEIs have become an integral part of management of patients with hypertension, congestive heart failure (CHF) and chronic renal disease. ACEIs, due to differences in their chemical structure, exert different pharmacological actions and can have protective or occasional damaging effects on different organs. The anesthesiologists are commonly involved in the management of patients treated With ACEIs. Thus, the role of ACEIs and their possible interaction with anesthetic agents must be an integral part of clinical decision-making during anesthesia Hemodynamic variation during anesthesia is mainly related to specific effects of anesthetic agents on sympathetic nervous system. Those with preoperative fasting, volume depletion and extended sympathetic blockade can have reduced vascular capacitance resulting in decreased venous return, reduced cardiac output and severe arterial hypotension. Angiotensin 11 (ANG2) a potent vasoconstrictor may counterbalance such hypotensive effect. During ACE inhibition ANG2 cannot counterbalance this hypotension. Thus, induction of anesthesia may cause severe hypotension in hypovolemic patients specifically in those receiving diuretics as a complement to ACEIs. Recent advances in RAS and the pharmacology of ACEls have identified some predisposing factors and risks associated with anesthesia in patients treated with ACEls. Practitioners should be vigilant, and readily have vasopressors, necessary fluids and other resuscitative measures for treatment of unexpected hemodynamic instability during anesthesia and surgery.
引用
收藏
页码:763 / 776
页数:14
相关论文
共 171 条
  • [1] ACKERMANN U, 1986, FASEB J, V45, P2111
  • [2] Altieri P I, 1994, P R Health Sci J, V13, P125
  • [3] ACE-INHIBITORS AND ATHEROSCLEROSIS
    AMBROSIONI, E
    BACCHELLI, S
    ESPOSTI, DD
    BORGHI, C
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1992, 8 : 129 - 133
  • [4] [Anonymous], 2002, JAMA
  • [5] The verdict from ALLHAT - Thiazide diuretics are the preferred initial therapy for hypertension
    Appel, LJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (23): : 3039 - 3042
  • [6] ORAL-ADMINISTRATION OF L-ARGININE AND CAPTOPRIL IN RATS PREVENTS CHRONIC-RENAL-FAILURE BY NITRIC-OXIDE PRODUCTION
    ASHAB, I
    PEER, G
    BLUM, M
    WOLLMAN, Y
    CHERNIHOVSKY, T
    HASSNER, A
    SCHWARTZ, D
    CABILI, S
    SILVERBERG, D
    IAINA, A
    [J]. KIDNEY INTERNATIONAL, 1995, 47 (06) : 1515 - 1521
  • [7] EFFECT OF ATRIAL PEPTIDES ON ALDOSTERONE PRODUCTION
    ATARASHI, K
    MULROW, PJ
    FRANCOSAENZ, R
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) : 1807 - 1811
  • [8] ATLAS SA, 1986, RECENT PROG HORM RES, V42, P207
  • [9] ENDOTHELIUM-MEDIATED VASODILATION DURING ACE-INHIBITION
    AUCHSCHWELK, W
    DUSKE, E
    CLAUS, M
    GRAF, K
    GRAFE, M
    FLECK, E
    [J]. EUROPEAN HEART JOURNAL, 1995, 16 : 59 - 65
  • [10] ROLE OF ATRIAL PEPTIDES IN BODY-FLUID HOMEOSTASIS
    BALLERMANN, BJ
    BRENNER, BM
    [J]. CIRCULATION RESEARCH, 1986, 58 (05) : 619 - 630